Approval · Notice of Compliance 22072 · 2019
REACTINE ALLERGY: Notice of Compliance 22072
Issued April 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22072
- Date
- April 5, 2019
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE ALLERGY | 02486954 | Marketed |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 5 MG per 5ML